EyePoint Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
31.08.23
/
50%
€9.00
Target price
31.08.24
€28.59
Performance (%)
-13.24%
End price
01.09.24
€7.81
Summary
This prediction ended on 01.09.24 with a price of €7.81. The price of EyePoint Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.24%. Cantor_Fitzgerald has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -2.920% | -2.920% | -12.067% |
| iShares Core DAX® | 1.663% | 6.945% | 18.807% |
| iShares Nasdaq 100 | 1.261% | 4.883% | 23.667% |
| iShares Nikkei 225® | 0.654% | 10.007% | 15.047% |
| iShares S&P 500 | 1.403% | 4.350% | 23.305% |
Comments by Cantor_Fitzgerald for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $31.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.20
14.09.23
14.09.23
€29.02
14.09.24
14.09.24
-23.45%
02.09.24
02.09.24
Stopped prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.48
20.06.24
20.06.24
-
20.06.25
20.06.25
4.33%
02.09.24
02.09.24